Supplemental Figure 1 from Anti-miRNA Oligonucleotide Therapy for Chondrosarcoma

Xiaojuan Sun,Yupeng Chen,Hongchuan Yu,Jason T. Machan,Ashna Alladin,Jose Ramirez,Ross Taliano,Jesse Hart,Qian Chen,Richard M. Terek

DOI: https://doi.org/10.1158/1535-7163.22506205

2023-01-01

Abstract:Lung metastatic burden quantified as number of nodules per lung and area of nodules as a percent of total lung area.

What problem does this paper attempt to address?

Supplementary Figure S2 from Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non–Small Cell Lung Cancer

Jhanelle E. Gray,Andreas Saltos,Tawee Tanvetyanon,Eric B. Haura,Ben Creelan,Scott J. Antonia,Michael Shafique,Hong Zheng,Wenjie Dai,James J. Saller,Zhihua Chen,Nishan Tchekmedyian,Kristen Goas,Ram Thapa,Theresa A. Boyle,Dung-Tsa Chen,Amer A. Beg

DOI: https://doi.org/10.1158/1078-0432.22471758.v1

2023-01-01

Abstract:Approach to assess levels of monocytic and PMN MDSC in patient PBMCs.
Supplementary Figure from Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy

Jiannong Li,Inna Smalley,Zhihua Chen,Jheng-Yu Wu,Manali S. Phadke,Jamie K. Teer,Thanh Nguyen,Florian A. Karreth,John M. Koomen,Amod A. Sarnaik,Jonathan S. Zager,Nikhil I. Khushalani,Ahmad A. Tarhini,Vernon K. Sondak,Paulo C. Rodriguez,Jane L. Messina,Y. Ann Chen,Keiran S.M. Smalley

DOI: https://doi.org/10.1158/1078-0432.22486712

2023-01-01

Abstract:Supplementary Figure from Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy
Figure S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419843.v1

2023-01-01

Abstract:Supplementary figure S3. Flow cytometry analyses of tumor draining lymph nodes.
Figure S4 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419840

2023-01-01

Abstract:Supplementary figure S4. Immunofluorescence on intratumoral lymphocytes and qRT-PCR assays on TH1-type chemokine expression
Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419831

2023-01-01

Abstract:Supplementary Table S1. Primers for qRT-PCR and MSP
Figure S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Xue Meng,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Li,Xiu‐Ping Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419846.v1

2023-01-01

Abstract:Supplementary figure S2. Gating strategies for flow cytometry analyses.
Figure S5 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419837.v1

2023-01-01

Abstract:Supplementary figure S5. DAC treatment did not increase the risk of osteosarcoma proliferation.
Table S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419828

2023-01-01

Abstract:Supplementary Table S2. Patient characteristics
Supplementary Data - Materials and Methods from Epigenetically Regulated Chromosome 14q32 miRNA Cluster Induces Metastasis and Predicts Poor Prognosis in Lung Adenocarcinoma Patients

Margarita González-Vallinas,Manuel Rodríguez-Paredes,Marco Albrecht,Carsten Sticht,Damian Stichel,Julian Gutekunst,Adriana Pitea,Steffen Sass,Francisco J. Sánchez-Rivera,Justo Lorenzo-Bermejo,Jennifer Schmitt,Carolina De La Torre,Arne Warth,Fabian J. Theis,Nikola S. Müller,Norbert Gretz,Thomas Muley,Michael Meister,Darjus F. Tschaharganeh,Peter Schirmacher,Franziska Matthäus,Kai Breuhahn

DOI: https://doi.org/10.1158/1541-7786.22517494

2023-01-01

Abstract:Supplementary Data - Materials and Methods
Table S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419825.v1

2023-01-01

Abstract:Supplementary Table S3. Demographics of the included 332 osteosarcomas.
Supplementary Fig. 1 from Discovery and Targeting of a Noncanonical Mechanism of Sarcoma Resistance to ADI-PEG20 Mediated by the Microenvironment

Leonard C. Rogers,Jeff C. Kremer,Caitlyn B. Brashears,Zongtao Lin,Zhixian Hu,Alliny C.S. Bastos,Adriana Baker,Nicole Fettig,Dong Zhou,Kooresh I. Shoghi,Carina A. Dehner,John S.A. Chrisinger,John S. Bomalaski,Benjamin A. Garcia,Toshinao Oyama,Eileen P. White,Brian A. Van Tine

DOI: https://doi.org/10.1158/1078-0432.23952345

2023-01-01

Abstract:Supplemental Figure 1. In vivo imaging.
Supplementary Figure from Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma

Qing Yang,Jiemiao Hu,Zhiliang Jia,Qi Wang,Jing Wang,Long Hoang Dao,Wendong Zhang,Sheng Zhang,Xueqing Xia,Richard Gorlick,Shulin Li

DOI: https://doi.org/10.1158/1078-0432.22486535

2023-01-01

Abstract:Supplementary Figure from Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma
Supplementary Fig. 4 from Discovery and Targeting of a Noncanonical Mechanism of Sarcoma Resistance to ADI-PEG20 Mediated by the Microenvironment

Leonard C. Rogers,Jeff C. Kremer,Caitlyn B. Brashears,Zongtao Lin,Zhixian Hu,Alliny C.S. Bastos,Adriana Baker,Nicole Fettig,Dong Zhou,Kooresh I. Shoghi,Carina A. Dehner,John S.A. Chrisinger,John S. Bomalaski,Benjamin A. Garcia,Toshinao Oyama,Eileen P. White,Brian A. Van Tine

DOI: https://doi.org/10.1158/1078-0432.23952336

2023-01-01

Abstract:Supplemental Figure 4. Validation of gene knockouts and ASS1 expression in MEFs.
NAMPT enhances LOX expression and promotes metastasis in human chondrosarcoma cells by inhibiting miR-26b-5p synthesis

Chih-Yang Lin,Yat-Yin Law,Cheng-Chieh Yu,Yu-Ying Wu,Sheng-Mou Hou,Wei-Li Chen,Shang-Yu Yang,Chun-Hao Tsai,Yuan-Shun Lo,Yi-Chin Fong,Chih-Hsin Tang

DOI: https://doi.org/10.1002/jcp.31345

Abstract:Chondrosarcoma is a malignant bone tumor that emerges from abnormalities in cartilaginous tissue and is related with lung metastases. Nicotinamide phosphoribosyltransferase (NAMPT) is an adipocytokine reported to enhance tumor metastasis. Our results from clinical samples and the Gene Expression Omnibus data set reveal that NAMPT levels are markedly higher in chondrosarcoma patients than in normal individuals. NAMPT stimulation significantly increased lysyl oxidase (LOX) production in chondrosarcoma cells. Additionally, NAMPT increased LOX-dependent cell migration and invasion in chondrosarcoma by suppressing miR-26b-5p generation through the c-Src and Akt signaling pathways. Overexpression of NAMPT promoted chondrosarcoma metastasis to the lung in vivo. Furthermore, knockdown of LOX counteracted NAMPT-facilitated metastasis. Thus, the NAMPT/LOX axis presents a novel target for treating the metastasis of chondrosarcoma.
Supplementary Fig. 5 from Discovery and Targeting of a Noncanonical Mechanism of Sarcoma Resistance to ADI-PEG20 Mediated by the Microenvironment

Leonard C. Rogers,Jeff C. Kremer,Caitlyn B. Brashears,Zongtao Lin,Zhixian Hu,Alliny C.S. Bastos,Adriana Baker,Nicole Fettig,Dong Zhou,Kooresh I. Shoghi,Carina A. Dehner,John S.A. Chrisinger,John S. Bomalaski,Benjamin A. Garcia,Toshinao Oyama,Eileen P. White,Brian A. Van Tine

DOI: https://doi.org/10.1158/1078-0432.23952333.v1

2023-01-01

Abstract:Supplemental Figure 5. Evidence against other possible growth support mechanisms and MEF toxicity.
Table S1D from Osteosarcoma Cells Secrete CXCL14 That Activates Integrin α11β1 on Fibroblasts to Form a Lung Metastatic Niche

Yanyang Xu,Chuangzhong Deng,Hongmin Chen,YiJiang Song,Huaiyuan Xu,Guohui Song,Xinliang Wang,Tianqi Luo,Weiqing Chen,Jiahui Ma,Anyu Zeng,Shujing Huang,Zhihao Chen,Jianchang Fu,Ming Gong,Yi Tai,Anfei Huang,Huixiong Feng,Jinxin Hu,Xiaojun Zhu,Qinglian Tang,Jinchang Lu,Jin Wang

DOI: https://doi.org/10.1158/0008-5472.25515858

2024-01-01

Abstract:List of shRNA or siRNA sequences used in this study.
Supplementary Figure S1 from Genomic Profiling of Radiation-Induced Sarcomas Reveals the Immunologic Characteristics and Its Response to Immune Checkpoint Blockade

Dong-Chun Hong,Jing Yang,Cong Sun,Yuan-Tao Liu,Lu-Jun Shen,Bu-Shu Xu,Yi Que,Xiaojun Xia,Xing Zhang

DOI: https://doi.org/10.1158/1078-0432.23523620

2023-01-01

Abstract:The flowchart showing patient screening and identification, and analysis steps for mRNA-seq and WES data. FS: fibrosarcoma; OS: osteosarcoma.
Supplementary Figure S3 from Combination Therapy Targeting Ribosome Biogenesis and Mrna Translation Synergistically Extends Survival in MYC-Driven Lymphoma

Jennifer R. Devlin,Katherine M. Hannan,Nadine Hein,Carleen Cullinane,Eric Kusnadi,Pui Yee Ng,Amee J. George,Jake Shortt,Megan J. Bywater,Gretchen Poortinga,Elaine Sanij,Jian Kang,Denis Drygin,Sean O'Brien,Ricky W. Johnstone,Grant A. McArthur,Ross D. Hannan,Richard B. Pearson

DOI: https://doi.org/10.1158/2159-8290.22530953

2023-01-01

Abstract:This figure shows supplementary data pertinent to Figure 3 including protein and cell immunofluorescence analysis data.
Supplementary Figure S4 from Combination Therapy Targeting Ribosome Biogenesis and Mrna Translation Synergistically Extends Survival in MYC-Driven Lymphoma

Jennifer R. Devlin,Katherine M. Hannan,Nadine Hein,Carleen Cullinane,Eric Kusnadi,Pui Yee Ng,Amee J. George,Jake Shortt,Megan J. Bywater,Gretchen Poortinga,Elaine Sanij,Jian Kang,Denis Drygin,Sean O'Brien,Ricky W. Johnstone,Grant A. McArthur,Ross D. Hannan,Richard B. Pearson

DOI: https://doi.org/10.1158/2159-8290.22530950

2023-01-01

Abstract:This figure shows supplementary data pertinent to Figure 4 including protein and cell death analysis data.
Supplemental Figure 2 from an Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2

Robert J.G. Cardnell,Carmen Behrens,Lixia Diao,YouHong Fan,Ximing Tang,Pan Tong,John D. Minna,Gordon B. Mills,John V. Heymach,Ignacio I. Wistuba,Jing Wang,Lauren A. Byers

DOI: https://doi.org/10.1158/1078-0432.22455642

2023-01-01

Abstract:Supplemental Figure 2. Unsupervised hierarchical clustering of mRNA in LUAD.

Supplemental Figure 1 from Anti-miRNA Oligonucleotide Therapy for Chondrosarcoma

Supplementary Figure S2 from Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non–Small Cell Lung Cancer

Supplementary Figure from Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy

Figure S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Figure S4 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Figure S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Figure S5 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Table S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Supplementary Data - Materials and Methods from Epigenetically Regulated Chromosome 14q32 miRNA Cluster Induces Metastasis and Predicts Poor Prognosis in Lung Adenocarcinoma Patients

Table S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Supplementary Fig. 1 from Discovery and Targeting of a Noncanonical Mechanism of Sarcoma Resistance to ADI-PEG20 Mediated by the Microenvironment

Supplementary Figure from Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma

Supplementary Fig. 4 from Discovery and Targeting of a Noncanonical Mechanism of Sarcoma Resistance to ADI-PEG20 Mediated by the Microenvironment

NAMPT enhances LOX expression and promotes metastasis in human chondrosarcoma cells by inhibiting miR-26b-5p synthesis

Supplementary Fig. 5 from Discovery and Targeting of a Noncanonical Mechanism of Sarcoma Resistance to ADI-PEG20 Mediated by the Microenvironment

Table S1D from Osteosarcoma Cells Secrete CXCL14 That Activates Integrin α11β1 on Fibroblasts to Form a Lung Metastatic Niche

Supplementary Figure S1 from Genomic Profiling of Radiation-Induced Sarcomas Reveals the Immunologic Characteristics and Its Response to Immune Checkpoint Blockade

Supplementary Figure S3 from Combination Therapy Targeting Ribosome Biogenesis and Mrna Translation Synergistically Extends Survival in MYC-Driven Lymphoma

Supplementary Figure S4 from Combination Therapy Targeting Ribosome Biogenesis and Mrna Translation Synergistically Extends Survival in MYC-Driven Lymphoma

Supplemental Figure 2 from an Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2